EA200001088A1 - TREATMENT OF GENERAL ALARM CONDITION WITH PAROXETINE - Google Patents
TREATMENT OF GENERAL ALARM CONDITION WITH PAROXETINEInfo
- Publication number
- EA200001088A1 EA200001088A1 EA200001088A EA200001088A EA200001088A1 EA 200001088 A1 EA200001088 A1 EA 200001088A1 EA 200001088 A EA200001088 A EA 200001088A EA 200001088 A EA200001088 A EA 200001088A EA 200001088 A1 EA200001088 A1 EA 200001088A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- paroxetine
- treatment
- alarm condition
- general alarm
- solvate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
- A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
- A61K31/4525—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
Landscapes
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Psychiatry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Способ лечения общего тревожного состояния включает введение эффективного нетоксичного количества пароксетина, или фармацевтически приемлемой соли, или его сольвата человеку или животному, при необходимости.Международная заявка была опубликована вместе с отчетом о международном поиске.A method of treating a general anxiety state involves administering an effective non-toxic amount of paroxetine, or a pharmaceutically acceptable salt, or its solvate to a human or animal, if necessary. The international application was published along with an international search report.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB9808479.1A GB9808479D0 (en) | 1998-04-22 | 1998-04-22 | Method of treatment |
PCT/US1999/008786 WO1999053919A1 (en) | 1998-04-22 | 1999-04-22 | Treatment of generalized anxiety disorder with paroxetine |
Publications (1)
Publication Number | Publication Date |
---|---|
EA200001088A1 true EA200001088A1 (en) | 2001-04-23 |
Family
ID=10830715
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EA200001088A EA200001088A1 (en) | 1998-04-22 | 1999-04-22 | TREATMENT OF GENERAL ALARM CONDITION WITH PAROXETINE |
Country Status (20)
Country | Link |
---|---|
EP (1) | EP1073437A4 (en) |
JP (1) | JP2002512189A (en) |
KR (1) | KR20010034817A (en) |
CN (1) | CN1298301A (en) |
AP (1) | AP2000001959A0 (en) |
AU (1) | AU3864899A (en) |
BG (1) | BG104939A (en) |
BR (1) | BR9909791A (en) |
CA (1) | CA2328896A1 (en) |
CZ (1) | CZ20003885A3 (en) |
EA (1) | EA200001088A1 (en) |
GB (1) | GB9808479D0 (en) |
HU (1) | HUP0101350A3 (en) |
ID (1) | ID27546A (en) |
IL (1) | IL139167A0 (en) |
NO (1) | NO20005286L (en) |
PL (1) | PL343494A1 (en) |
SK (1) | SK15672000A3 (en) |
TR (1) | TR200003082T2 (en) |
WO (1) | WO1999053919A1 (en) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2297550B (en) * | 1995-02-06 | 1997-04-09 | Smithkline Beecham Plc | Paroxetine hydrochloride anhydrate substantially free of bound organic solvent |
GB9514842D0 (en) * | 1995-07-20 | 1995-09-20 | Smithkline Beecham Plc | Novel formulation |
-
1998
- 1998-04-22 GB GBGB9808479.1A patent/GB9808479D0/en not_active Ceased
-
1999
- 1999-04-22 HU HU0101350A patent/HUP0101350A3/en unknown
- 1999-04-22 ID IDW20002124A patent/ID27546A/en unknown
- 1999-04-22 JP JP2000544323A patent/JP2002512189A/en not_active Withdrawn
- 1999-04-22 IL IL13916799A patent/IL139167A0/en unknown
- 1999-04-22 EP EP99921431A patent/EP1073437A4/en not_active Withdrawn
- 1999-04-22 BR BR9909791-5A patent/BR9909791A/en not_active IP Right Cessation
- 1999-04-22 CZ CZ20003885A patent/CZ20003885A3/en unknown
- 1999-04-22 TR TR2000/03082T patent/TR200003082T2/en unknown
- 1999-04-22 KR KR1020007011729A patent/KR20010034817A/en not_active Application Discontinuation
- 1999-04-22 AU AU38648/99A patent/AU3864899A/en not_active Abandoned
- 1999-04-22 WO PCT/US1999/008786 patent/WO1999053919A1/en not_active Application Discontinuation
- 1999-04-22 SK SK1567-2000A patent/SK15672000A3/en unknown
- 1999-04-22 CA CA002328896A patent/CA2328896A1/en not_active Abandoned
- 1999-04-22 EA EA200001088A patent/EA200001088A1/en unknown
- 1999-04-22 CN CN99805328A patent/CN1298301A/en active Pending
- 1999-04-22 AP APAP/P/2000/001959A patent/AP2000001959A0/en unknown
- 1999-04-22 PL PL99343494A patent/PL343494A1/en not_active Application Discontinuation
-
2000
- 2000-10-20 NO NO20005286A patent/NO20005286L/en not_active Application Discontinuation
- 2000-11-13 BG BG104939A patent/BG104939A/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN1298301A (en) | 2001-06-06 |
BG104939A (en) | 2001-09-28 |
ID27546A (en) | 2001-04-12 |
CA2328896A1 (en) | 1999-10-28 |
BR9909791A (en) | 2000-12-26 |
EP1073437A1 (en) | 2001-02-07 |
JP2002512189A (en) | 2002-04-23 |
NO20005286D0 (en) | 2000-10-20 |
PL343494A1 (en) | 2001-08-27 |
WO1999053919A1 (en) | 1999-10-28 |
SK15672000A3 (en) | 2001-04-09 |
TR200003082T2 (en) | 2001-01-22 |
KR20010034817A (en) | 2001-04-25 |
GB9808479D0 (en) | 1998-06-17 |
NO20005286L (en) | 2000-12-20 |
HUP0101350A3 (en) | 2002-06-28 |
EP1073437A4 (en) | 2003-04-16 |
AU3864899A (en) | 1999-11-08 |
HUP0101350A2 (en) | 2002-05-29 |
IL139167A0 (en) | 2001-11-25 |
AP2000001959A0 (en) | 2000-12-31 |
CZ20003885A3 (en) | 2001-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE425253T1 (en) | TRIBONECTINS | |
BG106104A (en) | Method for the treatment of diseases related to increased number of neutrophils or neutrophil overactivation | |
EA200100678A1 (en) | N-UREIDOALKYL-PIPERIDINES AS MODELS OF ACTIVITY OF RECEPTORS OF CHEMOKINES | |
EA200300503A1 (en) | NEW MEDICINAL COMPOSITIONS BASED ON SALTS OF TIOTROPY AND SALTS OF SALMETEROL | |
EA200200194A1 (en) | ANTAGONISTS OF THE CHEMOKINE RECEPTOR AND METHODS OF THEIR APPLICATION | |
EA200101116A1 (en) | METHOD OF TREATING FIBROSIS WITH THE HELP OF ALPHA-4-SUB-UNIT OF ANTAGONIST INTEGRIN | |
NO20021035D0 (en) | Methods of Using Rapidly Selective Serotonin Reuptake Inhibitors to Treat Sexual Dysfunction | |
DE3786893D1 (en) | PIPERIDE DERIVATIVE FOR THE TREATMENT OF PAIN. | |
PT998287E (en) | USES OF LEVOBUPIVACAINE | |
EA200200742A1 (en) | 1,2-DIARYLBENZYMIDAZOLEY FOR THE TREATMENT OF DISEASES ASSOCIATED WITH THE ACTIVATION OF MICROGLY | |
DK261490D0 (en) | NEW PHARMACEUTICAL COMPOUND | |
FI953899A0 (en) | Substituted azolone derivatives for the treatment of diseases caused by Helicobacter | |
DE60227283D1 (en) | SUBSTITUTED DIKETOPIPERAZINS AS OXYTOCIN ANTAGONISTS | |
EA200100653A1 (en) | THE METHOD OF STRUGGLE AGAINST MEMBERS OF ANIMALS | |
TR199700956T1 (en) | Indazole carboxamides. | |
EA199800866A1 (en) | METHOD OF REMOVAL OF PAIN | |
EA200000693A1 (en) | ANTAGONISTS OF THE CHEMOKINE RECEPTOR AND METHODS OF THEIR APPLICATION | |
PT1237562E (en) | PROCESS OF PREPARATION OF MYCANYAN EXTRACTS CONTAINING MICANOLIDE AND DIHYDROMICANOLID AND USES IN THE TREATMENT OF PROLIFERATIVE DISEASES | |
EA199800864A1 (en) | METHOD OF TREATMENT FOR PATIENTS CAUSED BY MIGRAINE | |
EA200400692A1 (en) | ANTAGONISTS OF THE CHEMOKINE RECEPTOR AND METHODS OF THEIR APPLICATION | |
EA200001088A1 (en) | TREATMENT OF GENERAL ALARM CONDITION WITH PAROXETINE | |
EA200100041A1 (en) | METHOD OF TREATMENT | |
EA200001140A1 (en) | COMPOUNDS INHIBITORS sPLA2 FOR THE TREATMENT OF DISEASE | |
ATE306278T1 (en) | TREATING BONE DISEASES WITH ADRENOMEDULLIN | |
TR199801801T2 (en) | Treatment of substance abuse. |